A consumer forum in Ernakulam has ruled against National Insurance in a dispute over a cancer treatment claim, holding that the company unfairly reduced the amount payable to the policyholder. The case centers on reimbursement for treatment that included stem cell therapy.
According to the forum’s findings, stem cell therapy is a recognized form of treatment and cannot be dismissed as if it falls outside accepted medical care. On that basis, the panel found fault with the insurer’s decision to cut the claim and said the restrictions applied in this case were not justified.
The order is significant for policyholders facing disputes over specialized or advanced cancer care. It signals that insurers may not be able to rely on blanket caps or narrow interpretations when a treatment is medically recognized and part of the patient’s covered care.
The ruling also highlights how consumer forums continue to scrutinize health insurance claim practices, especially in cases involving serious illnesses. For patients and families dealing with costly treatment, the decision reinforces the expectation that legitimate claims should be assessed fairly and without arbitrary reductions.
